Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

2.

New nitric oxide-donating drugs for the treatment of airway diseases.

Lagente V, Advenier C.

Curr Opin Investig Drugs. 2004 May;5(5):537-41. Review.

PMID:
15202728
3.

Nitric oxide-releasing nonsteroidal anti-inflammatory drugs: novel gastrointestinal-sparing drugs.

Bandarage UK, Janero DR.

Mini Rev Med Chem. 2001 May;1(1):57-70. Review.

PMID:
12369991
4.

Anti-inflammatory drugs in the 21st century.

Rainsford KD.

Subcell Biochem. 2007;42:3-27. Review.

PMID:
17612044
5.

Nitric Oxide. V. therapeutic potential of nitric oxide donors and inhibitors.

MuscarĂ¡ MN, Wallace JL.

Am J Physiol. 1999 Jun;276(6 Pt 1):G1313-6. Review.

PMID:
10362633
6.

The therapeutic potential of NO-NSAIDs.

Wallace JL, Del Soldato P.

Fundam Clin Pharmacol. 2003 Feb;17(1):11-20. Review.

PMID:
12588626
7.

NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.

Fiorucci S, Santucci L, Distrutti E.

Dig Liver Dis. 2007 Dec;39(12):1043-51. Epub 2007 Nov 7. Review.

PMID:
17997373
8.

Cyclo-oxygenase (COX) inhibiting nitric oxide donating (CINODs) drugs: a review of their current status.

Stefano F, Distrutti E.

Curr Top Med Chem. 2007;7(3):277-82. Review.

PMID:
17305570
9.

Nitric-oxide releasing molecules: a new class of drugs with several major indications.

Burgaud JL, Riffaud JP, Del Soldato P.

Curr Pharm Des. 2002;8(3):201-13. Review.

PMID:
11864065
10.

[New nonsteroidal anti-inflammatory agents: nitric oxide donors and selective cyclooxygenase-2 inhibitors].

Bannwarth B, Berenbaum F.

Rev Med Interne. 1999 Aug;20 Suppl 3:341s-345s. Review. French.

PMID:
10480184
11.

Role of nitric oxide in the gastrointestinal tract.

Lanas A.

Arthritis Res Ther. 2008;10 Suppl 2:S4. doi: 10.1186/ar2465. Epub 2008 Oct 17. Review.

12.

[Advances in the study of nitric oxide-donating drugs].

Zhang YH, Peng SX.

Yao Xue Xue Bao. 2009 Nov;44(11):1200-10. Review. Chinese.

PMID:
21355319
13.

Nitric oxide-modulating agents for gastrointestinal disorders.

Whittle BJ.

Expert Opin Investig Drugs. 2005 Nov;14(11):1347-58. Review.

PMID:
16255675
14.

Development of novel agents based on nitric oxide for the control of colon cancer.

Kozoni V, Rosenberg T, Rigas B.

Acta Pharmacol Sin. 2007 Sep;28(9):1429-33. Review.

15.

Nitric oxide and cardiovascular effects: new insights in the role of nitric oxide for the management of osteoarthritis.

Mackenzie IS, Rutherford D, MacDonald TM.

Arthritis Res Ther. 2008;10 Suppl 2:S3. doi: 10.1186/ar2464. Epub 2008 Oct 17. Review.

16.

What's new in NSAID pharmacotherapy: oral agents to injectables.

Atkinson TJ, Fudin J, Jahn HL, Kubotera N, Rennick AL, Rhorer M.

Pain Med. 2013 Dec;14 Suppl 1:S11-7. doi: 10.1111/pme.12278. Review.

PMID:
24373105
17.

Targeting nitric oxide with drug therapy.

Mason RP, Cockcroft JR.

J Clin Hypertens (Greenwich). 2006 Dec;8(12 Suppl 4):40-52. Review.

18.

Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.

Bertolini A, Ottani A, Sandrini M.

Curr Med Chem. 2002 May;9(10):1033-43. Review.

PMID:
12733982
19.

Nitric-oxide-donating NSAIDs as agents for cancer prevention.

Rigas B, Kashfi K.

Trends Mol Med. 2004 Jul;10(7):324-30. Review.

PMID:
15242680
20.

Nitric oxide-releasing NSAIDs: a review of their current status.

Fiorucci S, Antonelli E, Burgaud JL, Morelli A.

Drug Saf. 2001;24(11):801-11. Review.

PMID:
11665868

Supplemental Content

Support Center